<PAGE>
----------------------------
UNITED STATES | OMB APPROVAL |
SECURITIES AND EXCHANGE COMMISSION ----------------------------
Washington, D.C. 20549 | OMB Number: 3235-0145 |
| Expires: December 31, 1997 |
SCHEDULE 13G | Estimated average burden |
| hours per response...14.90 |
----------------------------
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
Molecular Devices Corporation
(Name of Issuer)
Common
(Title of Class of Securities)
60851C107
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A
fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such
class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
PAGE 1 OF 5 PAGES
<PAGE>
CUSIP NO. 60851C107 13G PAGE 2 OF 8 PAGES
- -------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Harden H. McConnell, Ph.D
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER (a) / /
OF A GROUP* (b) / /
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------------------------------------------------------------------
NUMBER OF SHARES (5) SOLE VOTING POWER
BENEFICIALLY 11,055
OWNED BY --------------------------------------------------
EACH REPORTING (6) SHARED VOTING POWER
PERSON WITH 616,720
--------------------------------------------------
(7) SOLE DISPOSITIVE POWER
11,055
--------------------------------------------------
(8) SHARED DISPOSITIVE POWER
616,720
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
627,775
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
PAGE 2 OF 5 PAGES
<PAGE>
ITEM 1.
(a) Name of Issuer:
Molecular Devices Corporation
(b) Address of Issuer's Principal Executive Offices:
1311 Orleans Drive, Sunnyvale, California
ITEM 2.
(a) Name of Person Filing
Harden H. McConnell
(b) Address of Principal Business Office or, if None, Residence:
Department of Chemistry
MUDD Bldg, Mail Code 5080
Stanford University
Stanford, CA 94305
(c) Citizenship:
United States
(d) Title of Class of Securities:
Common
(e) Cusip Number:
60851C107
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP
If the percent of the class owned, as of December 31 of the year covered
by the statement, or as of the last day of any month described in Rule
13d-1(b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a right
to acquire.
(a) Amount Beneficially Owned:
627,775
(b) Percent of Class:
6.7%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
11,055 *
(ii) shared power to vote or to direct the vote:
616,720 **
(iii) sole power to dispose or to direct the disposition of:
11,055 *
(iv) shared power to dispose or to direct the disposition of:
616,720 **
* Includes 11,055 shares that may be acquired within 60 days after December
31, 1997 pursuant to outstanding stock options.
** 596,720 Shares held by Harden M. McConnell and Sophia G. McConnell Trust,
of which Dr. McConnell is a co-trustee. 20,000 Shares held by McConnell
Family Limited Partnership, of which Dr. McConnell is a co-trustee.
PAGE 3 OF 5 PAGES
<PAGE>
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
Not applicable.
PAGE 4 OF 5 PAGES
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
February 10, 1998
----------------------------------------
Date
/s/ Harden H. McConnell
----------------------------------------
Signature
Harden H. McConnell
----------------------------------------
Name/Title
PAGE 5 OF 5 PAGES
